Santen Pharmaceutical. (SNPHF) Q2 2026 Earnings

May 12Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
0.12
0.18
0.24
0.3

Details

Expected EPS
0.193918386358
Actual EPS
0.30154824
Surprise EPS
0.11
Surprise Percent
+55.5%

Description

⁨Santen Pharmaceutical.⁩ (⁦SNPHF⁩) has reported earnings of ⁦0.30154824⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts